Literature DB >> 11861237

The importance of testing for adrenoleucodystrophy in males with idiopathic Addison's disease.

M D Ronghe1, J Barton, P E Jardine, E C Crowne, M H Webster, M Armitage, J T Allen, C G Steward.   

Abstract

X linked adrenoleucodystrophy (X-ALD) is considered to be a rare cause of Addison's disease, although several small series suggest a high incidence in young Addisonian males. A survey in the south west of England identified 12 male patients diagnosed with Addison's disease in the period 1987-99. In 10 of these (83%) X-ALD was the underlying cause; the other two were of autoimmune aetiology. Five boys had developed Addison's disease subsequent to the diagnosis of X-ALD. Of the remaining five, in three boys the diagnosis of X-ALD was considerably delayed (by six months to two years from that of Addison's disease) and in two it was only made as a result of this survey. We also identified a patient who presented with Addison's disease at the age of 5 years but was only diagnosed as having X-ALD at the age of 34 years; in the interim his diagnosis of adrenomyeloneuropathy had been missed. Our experience highlights the absolute necessity of measuring very long chain fatty acids in all males with idiopathic Addison's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861237      PMCID: PMC1719115          DOI: 10.1136/adc.86.3.185

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Reversal of early neurologic and neuroradiologic manifestations of X-linked adrenoleukodystrophy by bone marrow transplantation.

Authors:  P Aubourg; S Blanche; I Jambaqué; F Rocchiccioli; G Kalifa; C Naud-Saudreau; M O Rolland; M Debré; J L Chaussain; C Griscelli
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

2.  Lovastatin and sodium phenylacetate normalize the levels of very long chain fatty acids in skin fibroblasts of X- adrenoleukodystrophy.

Authors:  I Singh; K Pahan; M Khan
Journal:  FEBS Lett       Date:  1998-04-24       Impact factor: 4.124

Review 3.  The future for treatment by bone marrow transplantation for adrenoleukodystrophy, metachromatic leukodystrophy, globoid cell leukodystrophy and Hurler syndrome.

Authors:  W Krivit; L A Lockman; P A Watkins; J Hirsch; E G Shapiro
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

4.  Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy.

Authors:  E Shapiro; W Krivit; L Lockman; I Jambaqué; C Peters; M Cowan; R Harris; S Blanche; P Bordigoni; D Loes; R Ziegler; M Crittenden; D Ris; B Berg; C Cox; H Moser; A Fischer; P Aubourg
Journal:  Lancet       Date:  2000-08-26       Impact factor: 79.321

Review 5.  X-linked adrenoleukodystrophy: biochemical diagnosis and enzyme defect.

Authors:  R J Wanders; C W van Roermund; W Lageweg; B S Jakobs; R B Schutgens; A A Nijenhuis; J M Tager
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

6.  Adrenomyeloneuropathy presenting as Addison's disease in childhood.

Authors:  A Sadeghi-Nejad; B Senior
Journal:  N Engl J Med       Date:  1990-01-04       Impact factor: 91.245

Review 7.  Adrenoleukodystrophy.

Authors:  H W Moser; A Bergin; S Naidu; P W Ladenson
Journal:  Endocrinol Metab Clin North Am       Date:  1991-06       Impact factor: 4.741

8.  X-linked adrenoleukodystrophy in patients with idiopathic Addison disease.

Authors:  P Jorge; D Quelhas; P Oliveira; R Pinto; A Nogueira
Journal:  Eur J Pediatr       Date:  1994-08       Impact factor: 3.183

9.  Eighty-six cases of Addison's disease.

Authors:  M F Kong; W Jeffcoate
Journal:  Clin Endocrinol (Oxf)       Date:  1994-12       Impact factor: 3.478

10.  X-linked adrenoleukodystrophy with non-diagnostic plasma very long chain fatty acids.

Authors:  C R Kennedy; J T Allen; A H Fensom; S J Steinberg; R Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-06       Impact factor: 10.154

View more
  5 in total

1.  Early diagnosis of cerebral X-linked adrenoleukodystrophy in boys with Addison's disease improves survival and neurological outcomes.

Authors:  Lynda E Polgreen; Saydi Chahla; Weston Miller; Steven Rothman; Jakub Tolar; Teresa Kivisto; David Nascene; Paul J Orchard; Anna Petryk
Journal:  Eur J Pediatr       Date:  2011-01-29       Impact factor: 3.183

2.  Clinical profile of adrenoleukodysrophy.

Authors:  Shrikrishna V Acharya; Raju A Gopal; Tushar R Bandgar; Shashank R Joshi; Padma S Menon; Nalini S Shah
Journal:  Indian J Pediatr       Date:  2009-11-12       Impact factor: 1.967

3.  Adrenoleukodystrophy: a forgotten diagnosis in children with primary Addison's disease.

Authors:  Marta Nascimento; Nádia Rodrigues; Filipa Espada; Marcelo Fonseca
Journal:  BMJ Case Rep       Date:  2012-08-21

4.  Adrenoleukodystrophy in the Differential Diagnosis of Boys Presenting with Primary Adrenal Insufficiency without Adrenal Antibodies

Authors:  Michael R. Ryalls; Hoong-Wei Gan; James E. Davison
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-05-12

5.  Defining diagnostic cutoffs in neurological patients for serum very long chain fatty acids (VLCFA) in genetically confirmed X-Adrenoleukodystrophy.

Authors:  Tim W Rattay; Maren Rautenberg; Anne S Söhn; Holger Hengel; Andreas Traschütz; Benjamin Röben; Stefanie N Hayer; Rebecca Schüle; Sarah Wiethoff; Lena Zeltner; Tobias B Haack; Alexander Cegan; Ludger Schöls; Erwin Schleicher; Andreas Peter
Journal:  Sci Rep       Date:  2020-09-15       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.